(Q41081545)

26 September 2017

1 reference

title

Role of the new growth hormone-releasing secretagogues in the diagnosis of some hypothalamopituitary pathologies (English)

1 reference

26 September 2017

Casanueva FF

1

1 reference

26 September 2017

Micic D

2

1 reference

26 September 2017

Pombo M

3

1 reference

26 September 2017

Leal A

4

1 reference

26 September 2017

Bokser L

5

1 reference

26 September 2017

Zugaza JL

6

1 reference

26 September 2017

Dieguez C

7

1 reference

26 September 2017

language of work or name

1 reference

1 August 1996

1 reference

26 September 2017

number of pages

4

1 reference

based on heuristic

inferred from page(s)

published in

Metabolism

1 reference

26 September 2017

volume

45

1 reference

26 September 2017

issue

8 Suppl 1

1 reference

26 September 2017

page(s)

123-126

1 reference

Growth hormone neuroregulation and its alterations in disease states

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990105-5

Structure-activity relationships of a synthetic pentapeptide that specifically releases growth hormone in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990105-5

Parallel studies of His-DTrp-Ala-Trp-DPhe-Lys-NH2 and human pancreatic growth hormone-releasing factor-44-NH2 in rat primary pituitary cell monolayer culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990105-5

On the actions of the growth hormone-releasing hexapeptide, GHRP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990105-5

Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990105-5

Aetiology of idiopathic growth hormone deficiency in England and Wales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990105-5

High incidence of perinatal insult in children with idiopathic hypopituitarism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990105-5

Hypothalamic-pituitary function in growth hormone-deficient patients with pituitary stalk transection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990105-5

Magnetic resonance imaging in hypopituitarism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990105-5

Plasma growth hormone response to growth hormone-releasing hexapeptide (GH-RP-6) in children with short stature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990105-5

Deprivation of growth hormone-releasing hormone early in the rat's neonatal life permanently affects somatotropic function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990105-5

The growth hormone deficiency syndrome in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990105-5

Beneficial effects of growth hormone treatment in GH-deficient adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990105-5

Short stature and growth hormone deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990105-5

Influence of metabolic substrates and obesity on growth hormone secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990105-5

Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990105-5

Influence of sex, age and adrenergic pathways on the growth hormone response to GHRP-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990105-5

Inhibition of growth hormone release after the combined administration of GHRH and GHRP-6 in patients with Cushing's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990105-5

Growth hormone secretion after the administration of GHRP-6 or GHRH combined with GHRP-6 does not decline in late adulthood.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990105-5

Growth hormone (GH) responses to the combined administration of GH-releasing hormone plus GH-releasing peptide 6 in adults with GH deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990105-5

10.1016/S0026-0495(96)90105-5

7 January 2021

Identifiers

DOI

1 reference

26 September 2017

1 reference